Last edition
News about "Pre-Market Inspection"
USFDA Conducts Pre-Market Inspection at Pashamylaram Facility of Gland Pharma
The Company is committed to address the observations and will submit its response to USFDA within the stipulated time.
Pre-Market Inspection | 28/08/2023 | By Manvi | 454
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members